PSTV
PLUS THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.87
−3.25%Latest reported
- Last report date
- May 15, 2026
- EPS actual
- -$1.05
- EPS estimate
- -$0.95
- Revenue actual
- $1.0M
- Revenue estimate
- $972.8K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +19.5%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 15, 2026 | -$0.95 | -$1.05 | Miss -10.53% | $1.0M |
| Mar 12, 2026 | -$0.03 | -$0.00 | Beat 99.78% | $1.4M |
| Oct 30, 2025 | -$0.02 | -$0.04 | Miss -100.00% | $1.4M |
| Aug 14, 2025 | -$0.09 | -$0.01 | Beat 88.89% | $1.4M |
| May 30, 2025 | -$0.17 | -$0.56 | Miss -229.41% | $1.1M |
| Mar 27, 2025 | -$0.51 | -$0.67 | Miss -31.37% | $1.4M |
| Nov 14, 2024 | -$0.46 | -$0.46 | In line | $1.5M |
| Aug 14, 2024 | -$0.53 | -$0.71 | Miss -33.96% | $1.3M |
| May 15, 2024 | -$1.09 | -$0.75 | Beat 31.19% | $1.7M |
| Mar 5, 2024 | -$0.78 | -$0.70 | Beat 10.26% | $1.3M |
| Oct 31, 2023 | -$0.58 | -$1.00 | Miss -72.41% | $1.2M |
| Aug 14, 2023 | -$1.91 | -$0.59 | Beat 69.11% | $1.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026